Three-dimensional visualization developer Vital Images is keeping up with advances in multislice CT technology by optimizing its Vitrea workstation to handle data from the new scanners. The Minneapolis company rolled out the new version of Vitrea at last
Three-dimensional visualization developer Vital Images is keeping up with advances in multislice CT technology by optimizing its Vitrea workstation to handle data from the new scanners. The Minneapolis company rolled out the new version of Vitrea at last month's Radiological Society of North America meeting in Chicago.
Vitrea 1.2 is able to visualize the large data sets produced by multislice CT scanners quickly, thus enabling physicians to gain more detailed information for diagnosis and preoperative planning. The new version is particularly useful for virtual colonoscopy exams using 3-D-rendered CT data sets.
Other new features of the software include gantry tilt, automatic slice averaging, nonuniform slice spacing, 3-D measurements, dual-monitor display, and other dedicated visualization protocols. Like earlier versions of Vitrea, the software runs on the O2 workstation manufactured by Silicon Graphics of Mountain View, CA. Vitrea 1.2 will be available this quarter.
In other Vital Images news, the company reported that it is working on a calcium scoring option for CT scanners that will enable users to automate the calcium scoring process. Vital Images is working with Toshiba America Medical Systems of Tustin, CA, on the project, but the function will work with CT scanners from all vendors.
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.